Cerebral Spinal Fluid (CSF) Management Market Size & Forecast By Product (CSF Shunts, CSF Drainage), By Region (North America, Europe, Asia Pacific, Row), And Trend Analysis From 2012 To 2022
The global cerebral spinal fluid (CSF) management market is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View Research, Inc. Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in the investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.
Significant increase in geriatric population across the globe as well as raise in incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for prognosis of various nervous system associated disorders are expected to boost development.
Further Key Findings from the Study Suggest:
CSF management devices are expected to witness extensive competition owing to presence of several market players operating in this segment. Rise in number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.
CSF shunts captured the largest market share in terms of revenue generation in 2014.
These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.
CSF drainage is anticipated to witness lucrative growth over the forecast period.
This growth can be attributed to ongoing development for enhancing overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.
In 2014, North America accounted for the largest share with respect to revenue generation.
Factors contributive for the share include continuous increase in the number of Americans affected from Hydrocephalus coupled with ongoing research in neuroscience.
Asia Pacific is expected to propel with fastest CAGR owing to constantly improving healthcare system in the region.
Moreover, economic progress of Asia Pacific countries such as China has led to significant transformation of neurology and neurologic practices in the country. This is one of the key drivers to propel progress in this region in the coming years.
Some of the key players operating in the market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation;Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.
These players are engaged in development of novel platforms for CSF management.
Significant increase in geriatric population across the globe as well as raise in incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for prognosis of various nervous system associated disorders are expected to boost development.
Further Key Findings from the Study Suggest:
CSF management devices are expected to witness extensive competition owing to presence of several market players operating in this segment. Rise in number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.
CSF shunts captured the largest market share in terms of revenue generation in 2014.
These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.
CSF drainage is anticipated to witness lucrative growth over the forecast period.
This growth can be attributed to ongoing development for enhancing overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.
In 2014, North America accounted for the largest share with respect to revenue generation.
Factors contributive for the share include continuous increase in the number of Americans affected from Hydrocephalus coupled with ongoing research in neuroscience.
Asia Pacific is expected to propel with fastest CAGR owing to constantly improving healthcare system in the region.
Moreover, economic progress of Asia Pacific countries such as China has led to significant transformation of neurology and neurologic practices in the country. This is one of the key drivers to propel progress in this region in the coming years.
Some of the key players operating in the market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation;Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.
These players are engaged in development of novel platforms for CSF management.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information Procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 CSF MANAGEMENT INDUSTRY OUTLOOK
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 - 2022
3.3 CSF Management market dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advances driving growth
3.3.1.2 Growing base of aging population more prone to chronic diseases such as Parkinson’s and Alzheimer’s disorders
3.3.1.3 Increasing demand for minimally invasive surgeries
3.3.1.4 Rising cases of stroke and hydrocephalus
3.3.2 Market restraint analysis
3.3.2.1 Rising intricacies of clinical trials
3.3.2.2 Hospital budget constraints & alternative treatment facilities
3.4 Key opportunities prioritized, 2014
3.5 Industry analysis - Porter’s
3.6 CSF management PESTEL Analysis
CHAPTER 4 CSF MANAGEMENT PRODUCT OUTLOOK
4.1 Global CSF Management Revenue Share, by Product, 2014 & 2022
4.1.1 CSF shunts
4.1.1.1 CSF shunts devices market, 2012 - 2022 (USD Million)
4.1.2 CSF Drainage
4.1.2.1 CSF drainage devices market, 2012 - 2022 (USD Million)
CHAPTER 5 CSF MANAGEMENT REGIONAL OUTLOOK
5.1 CSF management revenue share, by region, 2014 & 2022
5.2 North America
5.2.1 North America CSF management market, 2012 - 2022 (USD Million)
5.3 Europe
5.3.1 Europe CSF management market, 2012 - 2022 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific CSF management market, 2012 - 2022 (USD Million)
5.5 RoW
5.5.1 RoW CSF management market, 2012 - 2022 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Strategy framework
6.2 Market participation categorization
6.3 B. Braun Melsungen AG
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Johnson & Johnson Services, Inc
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Integra LifeSciences Corporation
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Spiegelberg GmbH & Co. KG
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Medtronic, Inc.
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Sophysa
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 BECKERSMITH MEDICAL, Inc
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Phoenix Biomedical Corp.
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 M?ller Medical GmbH
6.11.1 Company overview
6.11.2 Financial performance
6.11.3 Product benchmarking
6.11.4 Strategic initiatives
6.12 Elekta AB
6.12.1 Company overview
6.12.2 Financial performance
6.12.3 Product benchmarking
6.12.4 Strategic initiatives
1.1 Information Procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 CSF MANAGEMENT INDUSTRY OUTLOOK
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 - 2022
3.3 CSF Management market dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advances driving growth
3.3.1.2 Growing base of aging population more prone to chronic diseases such as Parkinson’s and Alzheimer’s disorders
3.3.1.3 Increasing demand for minimally invasive surgeries
3.3.1.4 Rising cases of stroke and hydrocephalus
3.3.2 Market restraint analysis
3.3.2.1 Rising intricacies of clinical trials
3.3.2.2 Hospital budget constraints & alternative treatment facilities
3.4 Key opportunities prioritized, 2014
3.5 Industry analysis - Porter’s
3.6 CSF management PESTEL Analysis
CHAPTER 4 CSF MANAGEMENT PRODUCT OUTLOOK
4.1 Global CSF Management Revenue Share, by Product, 2014 & 2022
4.1.1 CSF shunts
4.1.1.1 CSF shunts devices market, 2012 - 2022 (USD Million)
4.1.2 CSF Drainage
4.1.2.1 CSF drainage devices market, 2012 - 2022 (USD Million)
CHAPTER 5 CSF MANAGEMENT REGIONAL OUTLOOK
5.1 CSF management revenue share, by region, 2014 & 2022
5.2 North America
5.2.1 North America CSF management market, 2012 - 2022 (USD Million)
5.3 Europe
5.3.1 Europe CSF management market, 2012 - 2022 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific CSF management market, 2012 - 2022 (USD Million)
5.5 RoW
5.5.1 RoW CSF management market, 2012 - 2022 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Strategy framework
6.2 Market participation categorization
6.3 B. Braun Melsungen AG
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Johnson & Johnson Services, Inc
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Integra LifeSciences Corporation
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Spiegelberg GmbH & Co. KG
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Medtronic, Inc.
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Sophysa
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 BECKERSMITH MEDICAL, Inc
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Phoenix Biomedical Corp.
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 M?ller Medical GmbH
6.11.1 Company overview
6.11.2 Financial performance
6.11.3 Product benchmarking
6.11.4 Strategic initiatives
6.12 Elekta AB
6.12.1 Company overview
6.12.2 Financial performance
6.12.3 Product benchmarking
6.12.4 Strategic initiatives
LIST OF TABLES
TABLE 1 CSF Management - Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Global CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 3 CSF Management market, by region, 2012 - 2022 (USD Million)
TABLE 4 CSF Management - Key market driver analysis
TABLE 5 CSF management - Key market restraint analysis
TABLE 6 North America CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 7 Europe CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 8 Asia Pacific CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 10 RoW CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 1 CSF Management - Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Global CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 3 CSF Management market, by region, 2012 - 2022 (USD Million)
TABLE 4 CSF Management - Key market driver analysis
TABLE 5 CSF management - Key market restraint analysis
TABLE 6 North America CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 7 Europe CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 8 Asia Pacific CSF management market, by product, 2012 - 2022 (USD Million)
TABLE 10 RoW CSF management market, by product, 2012 - 2022 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 CSF management market segmentation
FIG. 8 Global CSF management market, 2012 - 2022 (USD Million)
FIG. 9 CSF management market dynamics
FIG. 10 Key opportunities prioritized, 2014
FIG. 11 CSF management market Porter’s analysis
FIG. 12 CSF management market PESTEL analysis
FIG. 13 CSF management revenue share, by product, 2014 & 2022
FIG. 14 CSF shunts stimulation devices market , 2012 - 2022 (USD Million)
FIG. 15 CSF drainage stimulation devices market , 2012 - 2022 (USD Million)
FIG. 16 CSF Management market share, by region, 2014 & 2022
FIG. 17 North America CSF management market , 2012 - 2022 (USD Million)
FIG. 18 Europe CSF management market , 2012 - 2022 (USD Million)
FIG. 19 Asia Pacific CSF management market , 2012 - 2022 (USD Million)
FIG. 20 RoW CSF management market , 2012 - 2022 (USD Million)
FIG. 21 Strategy framework
FIG. 22 Participant categorization
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 CSF management market segmentation
FIG. 8 Global CSF management market, 2012 - 2022 (USD Million)
FIG. 9 CSF management market dynamics
FIG. 10 Key opportunities prioritized, 2014
FIG. 11 CSF management market Porter’s analysis
FIG. 12 CSF management market PESTEL analysis
FIG. 13 CSF management revenue share, by product, 2014 & 2022
FIG. 14 CSF shunts stimulation devices market , 2012 - 2022 (USD Million)
FIG. 15 CSF drainage stimulation devices market , 2012 - 2022 (USD Million)
FIG. 16 CSF Management market share, by region, 2014 & 2022
FIG. 17 North America CSF management market , 2012 - 2022 (USD Million)
FIG. 18 Europe CSF management market , 2012 - 2022 (USD Million)
FIG. 19 Asia Pacific CSF management market , 2012 - 2022 (USD Million)
FIG. 20 RoW CSF management market , 2012 - 2022 (USD Million)
FIG. 21 Strategy framework
FIG. 22 Participant categorization
